Author: admin

Epic Sequel “Sorcery & Sin in the Second World: A Tale of Two” Delivers Magic and Danger in a Realm Beyond Imagination

Epic Sequel "Sorcery & Sin in the Second World: A Tale of Two" Delivers Magic and Danger in a Realm Beyond Imagination
Award-winning author R.S. d’Arcy returns with “Sorcery & Sin in the Second World: A Tale of Two,” a gripping sequel filled with magic, peril, and romance. With masterful world-building and thrilling adventure, this must-read fantasy novel immerses readers in a realm where every choice has life-altering consequences.

In the highly anticipated sequel to Sorcery & Sin in the Second World, award-winning author R.S. d’Arcy returns with a spellbinding tale of love, betrayal, and supernatural intrigue. Sorcery & Sin in the Second World: A Tale of Two follows Pal and Rena, a married couple ripped apart in a mystical land, as they fight to reunite amid sorcery, treachery, and perilous quests. With riveting action, immersive world-building, and deep emotional stakes, d’Arcy’s latest novel is a must-read for fantasy lovers.

Beyond the portal in their backyard, Pal and Rena find themselves ensnared in an epic struggle for survival in the Second World. Imprisoned in a sorcerer’s tower, Pal must escape and harness his own magical abilities with the help of Kana, a long-lost neighbor who has lived in this mystical realm for decades. Meanwhile, Rena faces an even greater threat—forced into a treacherous marriage with the cunning Sorcerer King Sego, she must navigate a world of power-hungry enemies, all while guarding a secret that could alter the fate of both worlds.

Step Through the Portal: A World of Magic and Peril Awaits

D’Arcy masterfully blends heart-pounding adventure with gripping themes of love, loyalty, and resilience. Critics praise his world-building as “brilliantly realized,” immersing readers in a landscape where time moves differently and every choice comes with life-altering consequences.

Literary Titan hails the novel as “a must-read,” likening it to Lord of the Rings and Throne of Glass for its blend of rich fantasy lore, dynamic characters, and thrilling battles. With d’Arcy’s signature humor and intricate storytelling, this sequel is poised to be an unforgettable adventure for fantasy fans everywhere.

Don’t miss the next thrilling chapter in the Sorcery & Sin saga! Get your copy of Sorcery & Sin in the Second World: A Tale of Two today—available now on Kindle and in paperback exclusively on Amazon. Step through the portal and embark on an unforgettable adventure!

About the Author

R.S. d’Arcy is an award-winning author with a passion for storytelling that spans from classic literature to modern fantasy. A Long Island native, d’Arcy earned a Bachelor of Arts in Political Science from St. Joseph’s College before embarking on a diverse career path—including years spent working for a government agency with an “I” in its three-letter acronym.

His writing journey began during late-night shifts watching his newborn daughter, culminating in Sorcery & Sin in the Second World, which won the Literary Titan Book Award. Inspired by classic sword-and-sorcery tales and 1980s fantasy films, d’Arcy crafts stories that blend high-stakes adventure with compelling character arcs. Now residing in Southern Nevada with his wife and three dogs, he is hard at work on the next installment of the Sorcery & Sin series.

Stay connected with R.S. d’Arcy for the latest updates, behind-the-scenes insights, and exclusive content! Follow him on Instagram @r.s.darcy to dive deeper into the Sorcery & Sin universe, get sneak peeks of upcoming books, and join the adventure.

Media Contact
Company Name: Literary Titan
Contact Person: R. S. d’Arcy
Email: Send Email
Country: United States
Website: https://www.instagram.com/r.s.darcy/

BrightHub: Global Expansion to Revolutionize Southeast Asia’s Hybrid Stablecoin Infrastructure in 2025

BrightHub Finance, a leading global fintech enterprise, has announced the launch of its groundbreaking hybrid stablecoin infrastructure platform, set to debut in 50 countries worldwide. This landmark initiative, officially unveiling in February 2025, has garnered full support from key partners: Huione Pay, Love World, Huione Foundation, and PaiPay.

As a flagship project incubated by Huione (XONE Blockchain), BrightHub Finance has always been driven by technological innovation. By leveraging hybrid algorithmic stablecoin technology, the project is redefining the decentralized finance (DeFi) ecosystem. The global launch plan includes a $50,000,000 crowdfunding for each country node, marking a transformative step in the global digital economy.

Strategic Partnerships Driving BrightHub’s Global Growth

BrightHub Finance’s rapid expansion is backed by five key industry leaders:

  • Huione Pay: A global leader in payment services, Huione Pay provides comprehensive technical support and access to an extensive financial network, strengthening BrightHub’s stablecoin infrastructure with robust cross-border settlement capabilities.

  • Love World: As a global leader in premium, customized travel services, Love World offers essential networking opportunities for BrightHub’s expansion.

  • Huione Foundation: A key advocate for Web3 and decentralized ecosystems, the Huione Foundation provides financial support, technical resources, and global collaborations. Through Huione Labs, it fosters blockchain innovation, strengthening BrightHub’s Web3 positioning.

  • PaiPay: A payment service provider using advanced encryption technology and security measures. Co-developed with Huione Pay, PaiPay enables an independent encrypted wallet on Telegram, ensuring the security of user information and funds.

Unmatched Advantages of BrightHub’s Hybrid Stablecoin Platform

BrightHub Finance’s hybrid algorithmic stablecoin ecosystem addresses the challenges of volatility and transparency faced by traditional stablecoins. Its core features include:

  • Arbitrage and Cross-Chain Protocols: Utilizing smart contracts for efficient cross-chain capital flow, maximizing arbitrage opportunities.

  • Custodial Lending and Real-World Asset (RWA) Investments: Integrating decentralized finance with tangible assets, creating additional value opportunities for users.

  • Initial Split Offering (ISO) Algorithm Innovation: Utilizing reserve pools to mint stablecoins, ensuring stability, scalability, and trust within BrightHub’s ecosystem.

Global Expansion: Transforming Financial Systems Across 50 Countries

BrightHub Finance aims to democratize access to hybrid stablecoin technology across 50 nations. The platform’s expansion offers investment opportunities for country nodes, each requiring a $1,000,000 investment, providing long-term financial returns while fostering local DeFi ecosystems.

Beyond country nodes, BrightHub also offers three tiers of standard nodes starting at $500:

  • Basic Nodes

  • Standard Nodes

  • Genesis Nodes

Each tier comes with specific terms and conditions and will be available starting February 2025.

BrightHub DeFi Platform: Web3 Revolution Begins in March 2025

For Web3 users, BrightHub is set to launch its DeFi platform in March 2025, offering numerous opportunities, including airdrops and staking programs （BHC & USDB）. This will open up a new avenue for decentralized financial participation, creating value for users in the Web3 ecosystem.

BrightHub: Pioneering a New Digital Financial Era in Southeast Asia

As the first hybrid stablecoin infrastructure platform in Southeast Asia, BrightHub Finance is on a mission to accelerate decentralized financial technology and stimulate economic growth. By collaborating with XONE, Love World, and Huione Foundation, BrightHub is creating a transparent, efficient, and sustainable digital financial ecosystem.

This global expansion is more than a corporate milestone—it is a bold step toward reshaping the future of fintech, blockchain, and decentralized finance. With the official launch set for February 2025, BrightHub Finance is poised to become a dominant force in the global digital finance landscape.

Join BrightHub Finance: Sharing the Infinite Possibilities of Future Finance

BrightHub Finance invites investors, partners, and blockchain enthusiasts to join this groundbreaking global financial revolution. Whether you are looking for investment opportunities, strategic collaborations, or DeFi insights, we are here to assist.

Contact Us and Partnerships

For inquiries or partnership opportunities, please contact us at:

Countdown to February 2025 Begins! Stay tuned for more updates.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: BrightHub Finance
Contact Person: Ronnie lee
Email: Send Email
Country: Malaysia
Website: https://bhf.lol/lander

Embrace Change’s Inaugural Virtual Event Unites Over 100 BIWOC Leaders Globally, Marking a Historic Milestone in Professional Networking

First-of-its-kind virtual gathering showcases unprecedented global reach and engagement, celebrating excellence across industries through a groundbreaking awards ceremony.

The inaugural “Rise & Recognize: Connecting and Celebrating BIWOC Leaders” virtual event, hosted by Embrace Change on January 30, 2025, exceeded expectations with over 100 Black, Indigenous, and Women of Color (BIWOC) leaders participating from 84 cities across the globe, including attendees from Costa Rica and Australia. The event marked a significant milestone in professional networking for BIWOC leaders, bringing together a remarkable group that included 74 founders and entrepreneurs, 36 seasoned professionals with over 20 years of experience, and 35 C-suite executives, directors, and managers from 10 different sectors.

The event featured an engaging panel discussion on “The 2.0 of Networking: Leveraging the Power of Community in 2025,” moderated by Cynthia Pong, JD, founder and CEO of Embrace Change. Distinguished panelists included Lisa Campagñe, Sales Director at LinkedIn; Brandilyn Dumas, Esq., Real Estate Shareholder at Greenberg Traurig, LLP; and Dr. Kathryn Hall, Senior Vice President at The New York Academy of Medicine. The panelists shared powerful strategies for navigating professional spaces, with Dumas emphasizing “You belong in every room you enter,” Hall offering tactical approaches such as using the question “What is it about me that makes you think…?” as a tool for addressing biases and assumptions, and Campagñe advising leaders to “Separate fact from feeling” in professional situations in order to advance one’s leadership. The discussion generated extraordinary engagement, with participants contributing 5,699 emojis and maintaining an active, continuous dialogue throughout the event.

Hosted on the innovative AirMeet platform and produced by LaToya M. Smith, award-winning Founder and CEO of Brass City Media, Inc., the event showcased the power of expert virtual production. With over a decade of experience as an award-winning journalist, Smith has built her multimedia company into a leader in virtual and in-person event production, media consulting, and storytelling, partnering with government agencies, corporations, and community organizations to deliver meaningful, well-executed events that engage and inspire. The Rise & Recognize event featured dynamic networking sessions where participants connected in themed virtual rooms. High-demand tables in technology and innovation, consulting and professional services, nonprofit, higher education, medicine and healthcare, and entrepreneurial sectors reached full capacity, demonstrating the diverse professional backgrounds of attendees. The energy remained high throughout the event, amplified by vibrant music sets from renowned, Oakland-based DJ Karlita.

Pong’s powerful keynote address on the “State of BIWOC in the Workplace” resonated deeply with attendees, addressing critical issues facing women of color in leadership positions while emphasizing the importance of intentional career building and collective power. The address highlighted sobering statistics—including that women of color occupy only 7% of C-suite roles despite comprising over 20% of the US population—while offering strategic approaches to creating lasting change.

A highlight of the gathering was the inaugural Rise & Recognize Awards ceremony, celebrating excellence in three categories. The Impact & Leadership Award, recognizing BIWOC creating meaningful change and inspiring others to action, went to Ritha Pierre, Esq., General Counsel at RiseBoro Community Partnership. Pierre captured the spirit of the gathering in her acceptance speech, stating “We rise so that others may follow.” The Service Award, honoring those who go above and beyond in supporting others, was presented to Sangeetha Kowsik, Founder/Creator of Ihsan Ishan Design, while the Community Award, celebrating those who actively champion and uplift other BIWOC in the Embrace Change community, was awarded to Naseem Kapdi, Founder and Coach at Kimiya Coaching. The event recognized an impressive slate of finalists, including Jess Mar, PhD, Professor at University of Queensland; Jessica Qaasim, Head of Industry at Google; Markita Billups, Founder & Principal of Blackbird Strategic Solutions; Yvette Martínez-Vu, PhD, Grad School and Productivity Coach; Kesia Hudson, Managing Director of Zahn Innovation Center; and Dr. Olamide Jarrett, Global Health Practitioner. The distinguished judging panel included industry leaders Ashley Watkins Thomas, Carissa Begonia, Mary Lizardi, Rhapsodi Pierre-Jacques, Janna Zinzi, and Desree Cabrall-Njenga.

“The overwhelming response and engagement at Rise & Recognize demonstrates the critical need for spaces that specifically celebrate and connect BIWOC leaders,” said Cynthia Pong, JD. “The diversity of our attendees—from seasoned executives to emerging entrepreneurs—reflects the rich talent pool within our community and the power of meaningful connection.”

The event also recognized outstanding participant engagement, with Orion Brown, Founder of BlackTravelBox, winning the gold prize for most event engagement, followed by Karoline Hood of King Salama Safaris (silver) and Grace Kim from Dow Jones (bronze). Dr. Pilanda Watkins-Curry, Co-Founder and CTO at Olokun Minerals, and Tahjma VanBuren, Podcast Producer & SEO Specialist at iMoves Management, were awarded special prizes for their compelling responses about the importance of BIWOC-centered professional events.

This groundbreaking virtual gathering sets a new standard for professional networking events, demonstrating the power of intentional community building and recognition in advancing BIWOC leadership across industries.

Event Recording Access

Members of the EC Collective, a vibrant support community for BIWOC professionals, can access the full event replay as a complimentary benefit with their Annual or 6-Month membership (embracechange.nyc/ec-collective).

About Embrace Change

Embrace Change is an award-winning career coaching and training firm specializing in working with women of color and people of color. Founded in 2015, the company’s singular mission is to get all women of color—and people of color—the money, power, and respect they deserve in the workplace. Through innovative programming and community building, Embrace Change has established itself as a leading force in professional development for leaders of all backgrounds.

For more information, please visit embracechange.nyc or call 347-620-6328.

For any inquiries or to schedule an interview, send an email to happier@embracechange.nyc

Media Contact
Company Name: Embrace Change
Contact Person: Cynthia Pong, JD
Email: Send Email
Phone: 347-620-6328
City: New York
State: NY
Country: United States
Website: www.embracechange.nyc

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Embrace Change’s Inaugural Virtual Event Unites Over 100 BIWOC Leaders Globally, Marking a Historic Milestone in Professional Networking

Smart Transportation Market Recent Trends, Outlook, Size, Share, Top Companies, Industry Analysis, Future Development & Forecast – 2029

“Thales Group (France), Huawei (China), Siemens (Germany), Cisco (US), DNV (Norway), Cubic (US), Alstom (France), Toshiba (Japan), Veson Nautical (US), NEC Corporation (Japan), Bentley Systems (US), Indra (Spain), Trimble (US), TomTom (Netherlands), Conduent (US), Kapsch (Austria).”
Smart Transportation Market by Transportation Mode (Roadways, Railways, Airways, and Maritime), and End User (Government and Commercial Organizations) – Global Forecast to 2029.

The global smart transportation market is expected to expand from USD 129.72 billion in 2024 to USD 276.65 billion by 2029, registering a Compound Annual Growth Rate (CAGR) of 16.4%. This growth is fueled by several key factors, including rapid urbanization, increasing government initiatives for smart city development, and rising concerns over traffic congestion and environmental impact.

Advancements in IoT, AI, and 5G connectivity are playing a crucial role in transforming transportation infrastructure, driving the adoption of intelligent transportation systems. Additionally, the growing emphasis on reducing carbon emissions and enhancing transportation efficiency has led to substantial investments in smart mobility solutions.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=692

The market is further bolstered by the rise of electric vehicles (EVs), autonomous driving technologies, and mobility-as-a-service (MaaS) platforms, which are reshaping urban mobility. This expansion is particularly evident in major metropolitan areas, where smart transportation solutions help reduce congestion, optimize public transit, and improve overall urban mobility. By integrating these technologies, cities can achieve their sustainability objectives while enhancing the quality of life for residents.

“By transportation mode, Railways is expected to hold the highest growth rate during the forecast period.”

Railways are anticipated to hold the most significant growth rate during the forecast period, owing to their operational efficiency, commitment to sustainability, and the integration of advanced technologies. They are essential in connecting different regions and enabling economical, large-scale transportation for passengers and cargo. The sector includes innovations such as Smart Ticketing for seamless digital reservations, Passenger Information Systems that provide real-time updates, Freight Management systems for tracking and optimizing goods movement, Rail Traffic Management to ensure efficient scheduling and safety, and Rail Asset Management to oversee and maintain infrastructure. Implementing technologies like GIS tracking, security systems, and advanced analytics enhances operational efficiency. For example, countries such as Germany and the UK have implemented smart ticketing systems to improve passenger experiences, whereas Indian Railways uses freight management systems to enhance logistics efficiency. Due to growing emphasis on modernization and increased investments, railways are poised to emerge as a dominant player in the transportation industry, symbolizing a sustainable and technologically sophisticated option.

“Based on End User segment, Government will hold the largest market size during the forecast period.”

Governments are expected to hold the largest market share during the forecast period due to their critical role in funding, building, and managing transportation infrastructure and systems. Officials, as essential stakeholders, need to ensure public safety, promote economic development, and establish sustainable transportation solutions.

They make substantial investments in advanced technologies and solutions spanning various transportation modes: roads, railways, air travel, and maritime transport to tackle issues like urban expansion, traffic jams, and environmental sustainability. Government-supported vital solutions encompass Intelligent Mobility Systems aimed at traffic improvement, Rail Asset Management for monitoring and maintaining infrastructure, Airport Security Solutions to boost passenger safety, and Maritime Traffic Management for streamlined port operations. For instance, nations such as the United States and China have invested heavily in high-speed rail endeavors to enhance connectivity. In contrast, European countries have emphasized smart city projects integrating advanced traffic management with public transit networks. These efforts highlight governments’ vital obligation to foster innovation, improve infrastructure, and provide citizens and businesses with reliable, efficient, and sustainable transportation options.

“By Region, Europe is expected to hold the highest market share during the forecast period.”

Europe will emerge with the highest number of deployments and investments in the smart transportation market during the forecast period because of significant government initiatives, fast infrastructure development, and reforms focused on sustainability and smart cities. European countries are digging deeper into advanced technologies such as electric vehicles (EVs), autonomous transport systems, intelligent traffic regulation, and integrated transportation platforms to promote urban mobility and reduce carbon emissions.

Europe is a prime dynamic for smart transportation development with its emphasis on environmentally relevant projects and the EU’s further pressure to set up the grand deal and other national policies. For instance, Amsterdam and Paris have invested heavily in deploying electric vehicle infrastructure and equipment for the smart traffic management system to support urban mobility. The Horizon 2020 program of the European Union also supports research for smart mobility solutions, drawing on efforts to develop autonomous vehicles, smart public transportation systems, and sustainable mobility solutions across the region.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=692

Unique Features in the Smart Transportation Market

Smart transportation leverages real-time data analytics, AI-driven traffic monitoring, and IoT sensors to optimize traffic flow, reduce congestion, and enhance road safety. Intelligent traffic signals and adaptive control systems adjust to live traffic conditions, ensuring smoother commutes.

The adoption of Internet of Things (IoT) devices and Artificial Intelligence (AI) enables predictive maintenance, route optimization, and efficient traffic management. AI-powered analytics help in forecasting traffic patterns, reducing delays, and improving urban mobility.

Connected public transport systems, including real-time tracking, automated fare collection, and AI-powered scheduling, enhance commuter convenience. Mobile apps provide real-time updates on arrival times, routes, and occupancy levels, improving the efficiency of buses, trains, and metros.

The smart transportation market is evolving with the rise of electric vehicles (EVs) and autonomous vehicles (AVs). Governments and private companies are investing in EV infrastructure, including smart charging stations, while self-driving technology is set to revolutionize mobility and logistics.

MaaS integrates multiple transportation modes—including public transit, ride-sharing, bike rentals, and micro-mobility solutions—into a single, seamless digital platform. These platforms provide flexible, cost-effective, and sustainable urban mobility options.

Major Highlights of the Smart Transportation Market

Artificial Intelligence (AI), Internet of Things (IoT), and Big Data analytics are playing a transformative role in smart transportation. These technologies enable real-time traffic monitoring, predictive analytics, automated decision-making, and enhanced operational efficiency across transportation networks.

Governments worldwide are heavily investing in smart city projects, integrating intelligent traffic management, smart public transit, and sustainable mobility solutions to address urban congestion and improve quality of life. Policies promoting green mobility and digital transformation further accelerate market growth.

The rapid adoption of electric vehicles (EVs) and autonomous vehicles (AVs) is reshaping the transportation landscape. Governments and private sectors are collaborating to develop EV charging infrastructure, smart grid solutions, and self-driving vehicle technology to enhance safety and sustainability.

The shift towards Mobility-as-a-Service (MaaS) is gaining momentum, offering commuters integrated, flexible, and on-demand transportation solutions. Digital platforms that combine public transit, ride-hailing, bike-sharing, and car rentals into a single, app-based service are improving urban mobility and reducing congestion.

Innovative traffic control systems, AI-powered traffic signals, and smart intersections are optimizing urban mobility. Smart infrastructure developments, such as connected roads, intelligent lighting, and real-time congestion monitoring, contribute to improved efficiency and reduced travel times.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=692

Top Companies in the Smart Transportation Market

The major vendors covered in the Smart Transportation market are Thales Group (France), Huawei (China), Siemens (Germany), Cisco (US), DNV (Norway), Cubic (US), Alstom (France), Toshiba (Japan), Veson Nautical (US), NEC Corporation (Japan), Bentley Systems (US), Indra (Spain), Trimble (US), TomTom (Netherlands), Conduent (US), Kapsch (Austria), Hitachi (Japan), and Descartes (Canada). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches, enhancements, and acquisitions to expand their footprint in the Smart Transportation market.

Thales Group

Thales is a global technology company that provides solutions in defense, aerospace, space, security, and digital identity. It consists of five core segments: Aerospace, Defence & Security, Digital Identity & Security, and Space and Transport. The transport segment anchors the development of smarter transportation solutions for products such as rail signaling systems, integrated transport platforms, traffic management systems, and smart ticketing solutions. Among its offerings are SelTrac CBTC (Communication-Based Train Control), which automates train operations in urban rail networks, and TransCity, a smart ticketing management platform for multiple transport modes. In 2023, Thales launched next-generation autonomous train control systems aimed at improving efficiency and safety in rail networks, with deployments underway in cities across Europe and Asia. In 2023, Thales reported annual revenues of USD 20.8 billion. The company’s footprint extends across North and Latin America, Asia Pacific, the Middle East & Africa, and Europe.

Huawei

Huawei’s business is in telecommunications, IT infrastructure, and consumer electronics, structured around three key business segments: carrier, enterprise, and consumer. The enterprise business segment enables Huawei to drive its contributions to smart transportation solutions, such as the Urban Rail Cloud that converges and manages urban rail operations along with 5G-based V2X communication systems for connected vehicles and smart traffic management. Huawei also offers AI-powered Traffic Optimization Solutions for Urban Mobility. The expansion began in 2023, with on-the-ground installation in Asia and Europe to enable 5G AI traffic control systems for smart transportation. In 2023, the company earned an annual revenue of USD 99.4 billion and employed 207,272 people. It has operations across Latin America, Asia Pacific, the Middle East and Africa, and Europe, which gives it a strong global footprint.

Siemens

Siemens is a significant player in the Smart Transportation Market, providing innovative intelligent mobility solutions that improve both urban and intercity transportation efficiency. Siemens optimizes mobility with innovations in smart traffic management, linked car infrastructure, automated rail systems, and electrified transportation that use AI, IoT, and big data analytics. Siemens Mobility specializes on digital rail signaling, self-driving vehicle technology, and sustainable transportation solutions such as EV charging infrastructure and smart city traffic management. By integrating smart sensors, cloud-based analytics, and cybersecurity, Siemens is designing the future of safe, efficient, and sustainable transportation networks globally.

Cisco

Cisco (US) is a major player in the Smart Transportation Market, offering secure, scalable, and AI-powered networking solutions to improve urban mobility, public transit, and intelligent traffic systems. Cisco’s IoT-enabled infrastructure, edge computing, and cybersecurity solutions assist cities and transportation agencies in optimizing traffic management, linked vehicle communication (V2X), and real-time data analytics. Cisco Connected Roadways and Cisco Smart Mobility solutions provide for automated tolling, smart intersections, and predictive maintenance on rail and road networks. Cisco is paving the way for a safer, smarter, and more efficient global transportation ecosystem by combining cloud-based AI, 5G connectivity, and cybersecurity.

DNV

DNV (Norway) is a leading player in the Smart Transportation Market, specializing in risk management, safety assurance, and digital solutions for sustainable and efficient mobility. With expertise in autonomous vehicles, maritime transport, and smart infrastructure, DNV provides certification, cybersecurity assessments, and AI-driven predictive analytics to enhance the reliability of transportation systems. It plays a key role in decarbonization efforts, supporting electric and hydrogen-powered mobility, smart shipping, and digital twins for transport networks. By integrating IoT, blockchain, and data-driven risk analysis, DNV helps shape the future of safe, resilient, and sustainable smart transportation solutions worldwide.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/smart-transportation-market-692.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Smart Transportation Market Recent Trends, Outlook, Size, Share, Top Companies, Industry Analysis, Future Development & Forecast – 2029

Hanley Investment Group Arranges Sale of Chipotle Mexican Grill and Starbucks Drive-Thru in Rancho Cucamonga, Calif., for $6.22 Million

RANCHO CUCAMONGA, Calif. – Hanley Investment Group Real Estate Advisors, a nationally recognized real estate brokerage and advisory firm specializing in retail property sales, announced today that the firm arranged the sale of two stand-alone buildings occupied by a Chipotle Mexican Grill and the adjacent Starbucks Drive-Thru in Rancho Cucamonga, California. The sales price was $6.22 million.

Hanley Investment Group’s Executive Vice Presidents Bill Asher and Jeff Lefko represented the seller, Chase Partners Ltd., based in Glendale, California. The buyer, a private investor based in Los Angeles, was represented by Shirley Kim at Epique Realty, also of Los Angeles.

The property involved a complete rehabilitation of the facility and the expansion of Starbucks by the developer, Chase Partners Ltd., a leading retail and industrial developer in Southern California since 1993. Chase is an active developer of Starbucks and Chipotle sites, as well as other name-brand retail developments, with a dozen projects currently underway. Michael Carter served as the project manager for Chase.

“We generated multiple qualified offers primarily from Southern California-based buyers and leveraged our extensive broker relationships to procure a repeat all-cash buyer, ensuring a smooth and timely closing by year-end,” said Asher.

Built in 2003, the two freestanding properties occupied by a 2,508-square-foot Chipotle Mexican Grill and a 4,000-square-foot Starbucks Drive-Thru sit on a 1.31-acre parcel located at 10811-10831 Foothill Boulevard, near the signalized intersection of Foothill Boulevard (U.S. Route 66 with over 32,000 cars per day) and Aspen Avenue.

Starbucks (NASDAQ: SBUX) recently signed a new 10-year extension, expanding into the adjacent 2,500-square-foot space for a total of 4,000 square feet, showing its continued long-term commitment to this location. The Rancho Cucamonga Starbucks is a top 15% location nationwide, based on customer traffic (Placer.ai). Starbucks is the largest coffee house chain globally, with approximately 40,199 stores in 84 countries, and Fortune ranked it as one of the “World’s Most Admired Companies” from 2009 to 2024.

Chipotle (NYSE: CMG) is ranked on the Fortune 500 and is recognized on Fortune’s Most Admired Companies 2024 list and Time Magazine’s Most Influential Companies. There are over 3,600 restaurants in the United States, Canada, the United Kingdom, France, Germany, and Kuwait and it is the only restaurant company of its size that owns and operates all its restaurants in North America and Europe.

According to Asher, Chipotle has nine years remaining on its lease, having recently extended early for five years, demonstrating its ongoing investment in the site. The Rancho Cucamonga Chipotle is a top 25% location in California, based on customer traffic (Placer.ai).

Chipotle and Starbucks are located across from Terra Vista Town Center, one of Rancho Cucamonga’s most established and premier regional shopping centers. The 645,000-square-foot Terra Vista Town Center is ranked within the top 25% of power centers nationwide, based on customer traffic, according to Placer.ai. The center is anchored by Target, Hobby Lobby, and LA Fitness, along with other national tenants including Ross Dress for Less, Michaels, HomeGoods, Panera Bread, Wells Fargo, CVS, Bank of America, and Five Below. The property is ideally situated in the center of the city within minutes of the 10, 15, and 215 freeways. The property is located next to Rancho Cucamonga’s 44 million square feet of office and industrial space, which combined employs over 65,000 employees.

The population of Rancho Cucamonga grew 53.5% from 2010 to 2020. Within one mile of the property, the population experienced a 317.8% growth in population from 2010 to 2020. More than 276,000 residents with an average household income in excess of nearly $113,000 are within a five-mile radius.

Asher added, “It was one of our most sought-after listings in 2024, receiving significant interest and activity from both buyers and brokers. The combination of two corporate leases with two of the most recognizable national credit QSR tenants in the U.S., both with a 21-year operating history at the site, made it a highly desirable investment.”

About Hanley Investment Group

Hanley Investment Group Real Estate Advisors is a real estate brokerage and advisory services company with an over $11 billion transaction track record that specializes in the sale of retail properties nationwide. Our expertise, proven track record, and unwavering dedication to putting clients’ needs first set us apart in the industry. Hanley Investment Group creates value by delivering exceptional results through the use of property-specific marketing strategies, cutting-edge technology, and local market knowledge. Our nationwide relationships with investors, developers, institutions, franchisees, brokers, and 1031 exchange buyers are unparalleled in the industry, translating into maximum exposure and pricing for each property. With unmatched service, Hanley Investment Group has redefined the experience of selling retail investment properties. For more information, visit www.hanleyinvestment.com.

Media Contact
Company Name: Hanley Investment Group Real Estate Advisors
Contact Person: Bill Asher, Executive Vice President
Email: Send Email
Phone: 949.585.7684
Address:3500 East Coast Highway, Suite 100
City: Corona del Mar
State: California
Country: United States
Website: https://hanleyinvestmentgroup.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hanley Investment Group Arranges Sale of Chipotle Mexican Grill and Starbucks Drive-Thru in Rancho Cucamonga, Calif., for $6.22 Million

Triple Negative Breast Cancer FDA Approvals, Emerging Therapies, Pipeline Insights and Companies | DelveInsight

DelveInsight’s, “Triple Negative Breast Cancer Pipeline Insight” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Triple Negative Breast Cancer pipeline landscape. It covers the Triple Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Discover the latest drugs and treatment options in the Triple Negative Breast Cancer Pipeline. Dive into DelveInsight’s comprehensive report today! @ Triple Negative Breast Cancer Pipeline Outlook

 

Key Takeaways from the Triple Negative Breast Cancer Pipeline Report

  • In January 2025:- Merck Sharp & Dohme LLC- The purpose of this study is to evaluate the efficacy and safety of pembrolizumab (MK-3475) plus chemotherapy vs placebo plus chemotherapy as neoadjuvant therapy and pembrolizumab vs placebo as adjuvant therapy in participants who have triple negative breast cancer (TNBC).
  • In January 2025:- AstraZeneca:- This is a Phase IB/II, 2-stage, open-label, multicenter study to determine the efficacy and safety of durvalumab in combination with novel oncology therapies (i.e. therapies designed for immune modulation) with or without paclitaxel and durvalumab + paclitaxel as first-line treatment in patients with metastatic triple negative breast cancer (TNBC). The study is designed to concurrently evaluate potential novel treatment combinations with clinical promise using a 2-stage approach. The study will use a Simon 2-Stage design to evaluate which cohorts may proceed to expansion.
  • In January 2025: Mabwell (Shanghai) Bioscience Co., Ltd.- This study is a Phase 2, open-label,multicenter study designed to evaluate the efficacy and safety of 9MW2821monotherapy or combined with PD-1 inhibitor in locally advanced or metastatic Triple-Negative Breast Cancer.
  • DelveInsight’s Triple Negative Breast Cancer Pipeline analysis depicts a robust space with 75+ active players working to develop 80+ pipeline treatment therapies.
  • The leading Triple Negative Breast Cancer Companies such as Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., Infinity Pharmaceuticals, HiberCell, Inc., Zenith Epigenetics, BioLite, Inc., Abbisko Therapeutics, Phoenix Molecular Designs, OncoTherapy Science, ModernaTX, Inc, and others.
  • Promising Triple Negative Breast Cancer Pipeline Therapies such as Nanosomal Docetaxel Lipid Suspension (75 mg/m2), Taxotere® (100 mg/m2), B013+Nab-Paclitaxel, ZEN003694, Talazoparib, Pembrolizumab, Sacituzumab Govitecan-hziy, Datopotamab Deruxtecan (Dato-DXd), and others.

 

Stay ahead with the most recent pipeline outlook for Triple Negative Breast Cancer. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Triple Negative Breast Cancer Treatment Drugs

 

Triple Negative Breast Cancer Emerging Drugs Profile

 

  • Camrelizumab: Jiangsu HengRui Medicine

Camrelizumab (Airuika) is a humanized monoclonal antibody acts as immunomodulatory agent. It is formulated as solution for intravenous route. Camrelizumab is indicated as third-line treatment for recurrent or refractory classical hodgkin’s lymphoma, advanced hepatocellular carcinoma patients with oxaliplatin system chemotherapy, combined with pemetrexed and carboplatin for epidermal growth factor receptor (EGFR) gene mutation negative and anaplastic lymphoma kinase (ALK) negative, non-resectable locally advanced or metastatic first-line treatment of non-squamous non-small cell lung cancer (NSCLC), locally advanced or metastatic esophageal squamous cell carcinoma patients who have previously received first-line chemotherapy and whose disease has progressed or become intolerable and for the treatment of patients with advanced nasopharyngeal carcinoma who had disease progression after previous second-line and above chemotherapy or intolerable treatment. Currently the drug is in Phase III stage of Clinical trial evaluation for the treatment of Triple Negative Breast Cancer.

 

  • SKB264: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

SKB264 is an innovative TROP2-directed ADC which was developed by OptiDC, a well-known international ADC R&D platform of Kelun-Biotech, using a proprietary payload-linker strategy (Kthiol design strategy) that achieves an optimized balance of ADC safety and efficacy by combining novel irreversible antibody conjugation chemistry, pH-sensitive payload release mechanisms, and site-specific moderately potent toxin molecules with a DAR of 7.4 (novel topoisomerase I inhibitors). SKB264 has received Breakthrough Therapy Designations (BTDs) from the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) for the treatment of locally advanced or metastatic triple-negative breast cancer.

 

  • AK117: Akeso Biopharma

AK117, independently developed by Akeso, is a next generation of humanized lgG4 anti-CD47 antibody without hemagglutination effect. AK117 can bind to CD47 expressed on tumor cells and block the interaction between CD47 and SIRPα, in order to enhance the phagocytic activity of phagocytes on tumor cells, thereby inhibiting the growth of tumors. Currently, the drug is in Phase II stage of clinical trial evaluation for the treatment of Triple Negative Breast Cancer.

 

  • PLX038: ProLynx

PLX038 is a long-acting prodrug of the topoisomerase 1 (Top1) inhibitor, SN-38, which is also the active component of anti-cancer agents irinotecan and the ADC SC. Top1 inhibitors cause DNA breaks and kill tumors that are unable to repair the damage. Previously, Curie researchers showed that about one-third of TNBC patients have defects in DNA damage repair, and should respond to an effective SN-38-based therapy (Coussy et al., 2020). In PLX038, SN-38 is covalently bound to a circulating nanoparticle and is slowly released to provide free SN-38 with a long half-life, low Cmax, and high exposure – important facets for optimal safety and efficacy. Importantly, in preclinical studies PLX038 was shown to accumulate and be retained in solid tumors, where it slowly releases its SN-38. Currently, the drug is in Phase II stage of clinical trial evaluation for the treatment of Triple Negative Breast Cancer.

 

  • PMD-026: Phoenix Molecular Designs

PhoenixMD’s lead candidate, PMD-026, is the first RSK inhibitor being developed for the treatment of TNBC. It is a pill that is convenient for patients as opposed to intravenous delivery, the mode most commonly used to deliver chemotherapy. PMD-026 was designed for TNBC because RSK2 was specifically identified as the key kinase that drives the growth of this breast cancer subtype5, 6. PMD-026 is well-tolerated in breast cancer patients and can stop tumor growth for up to 5 months based on Phase 1 data. PFS in women with TNBC is three times longer for patients that express high levels of RSK2 activation as compared to those with low RSK2 activation. Preclinical data shows PMD-026 has the potential to be a platform technology for chemotherapy, hormone therapy and/or immunotherapy sensitization for a wide range of refractory cancers in the future. Currently the drug is in Phase I stage of Clinical trial evaluation for the treatment of Triple Negative Breast Cancer.

 

Explore groundbreaking therapies and clinical trials in the Triple Negative Breast Cancer Pipeline. Access DelveInsight’s detailed report now! @ New Triple Negative Breast Cancer Drugs

 

Triple Negative Breast Cancer Companies

Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., Infinity Pharmaceuticals, HiberCell, Inc., Zenith Epigenetics, BioLite, Inc., Abbisko Therapeutics, Phoenix Molecular Designs, OncoTherapy Science, ModernaTX, Inc, and others

 

Triple Negative Breast Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

  • Oral
  • Parenteral
  • intravenous
  • Subcutaneous
  • Topical.

 

Triple Negative Breast Cancer Products have been categorized under various Molecule types such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy

 

Unveil the future of Triple Negative Breast Cancer Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Triple Negative Breast Cancer Market Drivers and Barriers

 

Scope of the Triple Negative Breast Cancer Pipeline Report

  • Coverage- Global
  • Triple Negative Breast Cancer Companies- Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., Infinity Pharmaceuticals, HiberCell, Inc., Zenith Epigenetics, BioLite, Inc., Abbisko Therapeutics, Phoenix Molecular Designs, OncoTherapy Science, ModernaTX, Inc, and others.
  • Triple Negative Breast Cancer Pipeline Therapies- Nanosomal Docetaxel Lipid Suspension (75 mg/m2), Taxotere® (100 mg/m2), B013+Nab-Paclitaxel, ZEN003694, Talazoparib, Pembrolizumab, Sacituzumab Govitecan-hziy, Datopotamab Deruxtecan (Dato-DXd), and others.
  • Triple Negative Breast Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Triple Negative Breast Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

Get the latest on Triple Negative Breast Cancer Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Triple Negative Breast Cancer Companies, Key Products and Unmet Needs

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Triple Negative Breast Cancer: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Triple Negative Breast Cancer – DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Camrelizumab: Jiangsu HengRui Medicine
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. AK117: Akeso Biopharma
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. PMD-026: Phoenix Molecular Designs
  15. Drug profiles in the detailed report…..
  16. Inactive Products
  17. Triple Negative Breast Cancer Key Companies
  18. Triple Negative Breast Cancer Key Products
  19. Triple Negative Breast Cancer- Unmet Needs
  20. Triple Negative Breast Cancer- Market Drivers and Barriers
  21. Triple Negative Breast Cancer- Future Perspectives and Conclusion
  22. Triple Negative Breast Cancer Analyst Views
  23. Triple Negative Breast Cancer Key Companies
  24. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/report-store/dyspepsia-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Triple Negative Breast Cancer FDA Approvals, Emerging Therapies, Pipeline Insights and Companies | DelveInsight

Sveagle Plumbing Now Offers Professional Plumbing Service in Frisco

Sveagle Plumbing Now Offers Professional Plumbing Service in Frisco

Frisco, TX – Sveagle Plumbing, a trusted name in the plumbing industry since 1969, is proud to announce its expanded services as a premier plumber in Frisco. With a commitment to excellence and customer satisfaction, Sveagle Plumbing offers a wide range of plumbing services to meet the diverse needs of Frisco residents and businesses.

Sveagle Plumbing has built a solid reputation as one of the best plumbers in Frisco, TX, providing top-quality plumbing solutions for over five decades. The company’s team of skilled technicians is equipped to handle everything from routine maintenance to complex plumbing problems, ensuring that customers receive reliable and efficient service.

Mitch Kenney, spokesperson for Sveagle Plumbing, stated, “We are thrilled to extend our services to the Frisco community. Our team is dedicated to delivering exceptional plumbing solutions that not only meet but exceed our customers’ expectations. We understand the importance of prompt and professional service when it comes to plumbing issues, and we’re committed to being the go-to plumber in Frisco that residents can trust.”

As a leading provider of plumbing services in Frisco, Sveagle Plumbing offers a comprehensive suite of solutions, including water heater repair, drain cleaning, leak detection, and emergency plumbing services. The company’s technicians are highly trained and equipped with state-of-the-art tools to diagnose and resolve plumbing problems efficiently.

One of the key factors that sets Sveagle Plumbing apart from other plumbers in Frisco, TX, is their commitment to transparency and fair pricing. The company offers free estimates and flat-rate pricing, ensuring that customers know the exact cost of the job upfront, with no hidden fees or surprises.

Sveagle Plumbing’s expansion into the Frisco area is a testament to their growth and dedication to serving more communities in Texas. The company’s reputation for quality workmanship and exceptional customer service has made them a preferred choice for both residential and commercial plumbing needs.

For those seeking plumbing services in Frisco, TX, Sveagle Plumbing offers 24/7 emergency support, providing peace of mind to customers facing urgent plumbing issues. Their team of experienced technicians is always ready to respond promptly to any plumbing emergency, minimizing damage and restoring normalcy as quickly as possible.

Sveagle Plumbing’s commitment to excellence extends beyond their technical expertise. The company places a strong emphasis on customer education, helping clients understand their plumbing systems and providing valuable tips for maintenance and prevention of future issues. This approach not only solves immediate problems but also helps customers save money in the long run by avoiding potential plumbing disasters.

As part of their dedication to the Frisco community, Sveagle Plumbing is actively involved in local initiatives and supports various community programs. The company believes in giving back to the areas they serve, further solidifying their position as a trusted local plumbing business

With their expansion into Frisco, Sveagle Plumbing is poised to become the go-to plumbing service in the area. Their combination of experience, expertise, and customer-focused approach makes them an ideal choice for anyone in need of reliable plumbing solutions.

Residents and businesses in Frisco can now benefit from Sveagle Plumbing’s professional services, joining the long list of satisfied customers who have experienced the company’s commitment to quality and excellence.

For more information, please contact Mitch Kenney at +19704805031.

About Sveagle Plumbing:

Sveagle Plumbing is a leading plumbing company serving Frisco and surrounding areas in Texas. With over five decades of experience, Sveagle Plumbing has built a reputation for providing high-quality plumbing services, exceptional customer care, and innovative solutions to complex plumbing problems. The company’s team of licensed technicians is dedicated to delivering prompt, reliable, and efficient plumbing services to both residential and commercial clients.

Media Contact
Company Name: Sveagle Plumbing
Contact Person: Mitch Kenney
Email: Send Email
Phone: +19704805031
Address:619 Main St #4A
City: Frisco
State: CO
Country: United States
Website: https://sveagle.com/

Carlsbad Auto Service Supports Foster Care Youth With Generous Donation

Carlsbad Auto Service Supports Foster Care Youth With Generous Donation
Carlsbad Auto Service Continues to Champion Foster Kids and Community Success

Carlsbad, CA – Carlsbad Auto Service, a proud supporter of Walden Family Services, continues its commitment to fostering positive change in the community by supporting foster care youth. Owned and operated by a dynamic team of women, Carlsbad Auto Service promotes success and empowerment for young women and aspiring young mechanics alike.

Meet Isaiah, an inspiring young man whose journey is a testament to resilience and hope. Growing up in foster care from the age of seven, Isaiah faced incredible challenges, including being placed in over 30 homes. Despite this instability, he found a loving and supportive foster home where he lived for two years and graduated from Adelanto High School with honors.

At 18, Isaiah joined Walden’s Transitional Housing Program (THP) and worked tirelessly to stabilize his life. Through sheer determination, he overcame obstacles like limited family support and transportation issues. Even in the face of these challenges, Isaiah stayed committed to providing for his son, maintaining his job, and remaining in good standing with the THP program.

But Isaiah’s story doesn’t end there. Thanks to the generous support of Carlsbad Auto Service, Isaiah now has reliable transportation! Carlsbad Auto Service recently donated two vehicles to Walden Family Services, and Isaiah was the proud recipient of a fixed-up Toyota 4Runner. This invaluable gift has not only provided Isaiah with the means to maintain his job and care for his son but has also given him the flexibility to explore further education and pursue his dream of joining the Navy.

“We believe in giving back to our community and supporting foster youth like Isaiah,” said Jaime Sanders, co-owner of Carlsbad Auto Service. “Fixing up cars and donating them to foster kids is just one way we can make a positive impact. Seeing Isaiah’s determination and knowing that our efforts can help him achieve his dreams is incredibly rewarding.”

“At Carlsbad Auto Service, we believe that every young person deserves a chance to thrive,” said Eva Papousek, co-owner of Carlsbad Auto Service. “By donating vehicles and providing practical support, we hope to empower foster youth like Isaiah to take control of their futures. It’s not just about the cars; it’s about creating opportunities and making a meaningful difference in our community.”

Carlsbad Auto Service has a longstanding history of supporting Walden Family Services through generous donations and active involvement in fundraising efforts over the past few years. Their commitment to the community ensures positive effects that extend beyond car donations, promoting success and independence for foster youth and others.

Isaiah’s story embodies the power of resilience, dedication, and the incredible impact of community support. His journey is a shining example of what can be achieved with the right support and opportunities.

Carlsbad Auto Service’s dedication to the community and foster care is truly making a difference. Their continuous support of Walden Family Services and foster kids ensures that young individuals like Isaiah have the resources they need to build a brighter future.

For more information on how you can support Walden Family Services and make a difference in the lives of foster care youth, please visit Walden Family Services.

About Carlsbad Auto Service:

Carlsbad Auto Service is a woman-owned business that prides itself on delivering top-notch auto repair services while supporting community initiatives. Their commitment to excellence and community welfare sets them apart as a beacon of positive change in Carlsbad. Learn more at: www.carlsbadautoservice.com.

About Walden Family Services:

Established in 1976, Walden Family Services focuses on providing critical support to foster children, youth, and adoptive families across Southern California. Through diverse programs and initiatives, Walden aims to create stable, nurturing environments that enable children and young adults in need to thrive and realize their full potential.

Media Contact
Company Name: Walden Family Services
Contact Person: Shannon Lynard
Email: Send Email
Phone: +16195845777
Address:8525 Gibbs Dr #100
City: San Diego
State: CA
Country: United States
Website: https://waldenfamily.org/locations/corporate-office-san-diego/

Certificate Hero Revolutionizes Insurance Certificate Management with Gen AI-Powered Upgrade

Dedham, MA – In a significant development poised to change the insurance industry, Certificate Hero has unveiled a major upgrade to its innovative Contract Analysis platform. This enhancement brings remarkable improvements in certificate generation and issuance, placing Certificate Hero at the forefront of AI-driven insurance solutions.

As the insurance sector rapidly adapts, with more than 50% of insurers incorporating artificial intelligence in various ways, Certificate Hero’s latest upgrade meets the increasing need for efficiency and precision in managing insurance certificates. The company’s SaaS solution enables insurance brokers, carriers, and their clients to effortlessly issue and manage certificates of insurance from beginning to end.

Key features of the upgrade include:

1. Enhanced AI Model: Utilizing advanced artificial intelligence, the new model quickly and accurately identifies and extracts insurance-related requirements from searchable and non-searchable contracts.

2. Intuitive Multi-View Navigation: Improved workflows with better comparison capabilities between contract requirements and policy coverages enhance the user experience.

3. Unified Contract Examination: A single-view interface with Quick Find functionality allows users to easily review important sections of contracts.

4. AI-Powered Q&A: By leveraging the new model and the capabilities of artificial intelligence, users can now extract data and receive immediate answers to questions regarding the contract.

“Our latest upgrade represents a major step forward in managing insurance certificates,” said Michael Yanoff, CEO of Certificate Hero. “By harnessing the power of AI and machine learning, we’re enhancing efficiency and changing the way insurance professionals interact with complex contract data.” This innovation aligns with industry trends, as insurers are increasingly adopting AI for predictive analytics, risk modelling, and better customer insights. Certificate Hero’s platform addresses these demands by providing a comprehensive solution that saves time, reduces errors, and ensures the issuance of the most accurate certificates in the most efficient way possible.

As the insurance industry increasingly adopts digital transformation, the Certificate Hero platform establishes a new benchmark for AI-driven solutions. By merging advanced technology with a focus on user experience, Certificate Hero is set to spearhead the transformation of insurance certificate management for the foreseeable future.

For more details about Certificate Hero and its groundbreaking platform, visit https://certificatehero.com

Media Contact
Company Name: Certificate Hero
Contact Person: Michael Yanoff
Email: Send Email
Country: United States
Website: https://certificatehero.com

Alzheimer’s Disease FDA Approvals, Clinical Trials, Emerging Drugs, Pipeline Insights and Companies | DelveInsight

DelveInsight’s, “Alzheimer’s Disease Pipeline Insight” report provides comprehensive insights about 110+ companies and 120+ pipeline drugs in Alzheimer’s-disease pipeline landscape. It covers the Alzheimer’s Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Alzheimer’s Disease therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

 

Explore the comprehensive insights by DelveInsight and stay ahead in understanding the Alzheimer’s Disease Treatment Landscape. Click here to read more @ Alzheimer’s Disease Pipeline Outlook

 

Key Takeaways from the Alzheimer’s Disease Pipeline Report

  • In January 2025:- Novo Nordisk- The study is being conducted to understand how the medicine, semaglutide, affects the immune system and other biological processes in people with Alzheimer’s disease. Semaglutide is a medicine that doctors can prescribe in some countries for the treatment of type 2 diabetes and excess body weight.
  • In January 2025:- Hoffmann-La Roche:- The purpose of this study is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics, and pharmacodynamics of multiple-ascending intravenous (IV) doses of RO7126209 in participants with prodromal or mild to moderate Alzheimer’s disease (AD), who are amyloid positive based on amyloid positron emission tomography (PET) scan.
  • In January 2025:- Bigespas Ltd:- Multicenter Randomized Double-blind Placebo-controlled Three-arm Parallel-group Clinical Study to Evaluate the Efficacy and Safety of DMB-I in the Treatment of Dementia Associated With Alzheimer’s Disease. The purpose of this study is to assess the efficacy and safety of DMB-I for the treatment of patients with Alzheimer type dementia.
  • In January 2025:- Eisai Inc.:- The primary objective of the study is to determine the dose response of E2814, when concurrently administered with lecanemab, on the change from baseline at 6 months in cerebrospinal fluid (CSF) microtubule-binding region (MTBR)-tau-243 in participants with early Alzheimer’s disease (AD).
  • DelveInsight’s Alzheimer’s Disease pipeline report depicts a robust space with 110+ active players working to develop 120+ pipeline therapies for Alzheimer’s Disease treatment.
  • The leading Alzheimer’s Disease Companies such as AriBio Co., Ltd., Eli Lilly & Co., Cognition Therapeutics, AbbVie Inc., Allyx Therapeutics, Inc., Cassava Sciences, BioVie Inc., Novo Nordisk, Alector Inc., Longeveron Inc., TrueBinding, Inc., VT BIO, Luye Pharma Group Ltd., Lexeo Therapeutics, Merck Sharp & Dohme LLC, Regeneration Biomedical, Alnylam Pharmaceuticals, Sinotau Pharmaceutical Group, Eisai Inc., Shanghai Hengrui Pharmaceutical Co., Ltd and others.
  • Promising Alzheimer’s Disease Therapies such as Aricept, INM-176, SAR110894, Donepezil, CPC-201, ENA713, Remternetug, and others.

 

Stay informed about the cutting-edge advancements in Alzheimer’s Disease treatments. Download for updates and be a part of the revolution in care @ Alzheimer’s Disease Clinical Trials Assessment

 

Alzheimer’s Disease Emerging Drugs Profile

 

  • AR1001: AriBio Co., Ltd.

AR1001 is a selective inhibitor of phosphodiesterase 5. This new pyrrolo-pyrimidinone was first developed for treatment of erectile dysfunction in South Korea, and is now being tested for Alzheimer’s Disease. Its maker claims AR1001 to be 10-fold more potent at inhibiting PDE5, and better at entering the brain, than approved PDE5 inhibitors, including sildenafil.

 

  • NE3107: BioVie

NE3107 is an orally available small molecule with potential anti-inflammatory and insulin-sensitizing properties that can cross the blood-brain barrier. It was originally developed by NeurMedix and acquired by BioVie in April. The experimental molecule works by blocking the activation of two major regulators of inflammatory pathways: extracellular signal regulated kinase (ERK) and nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB).

 

  • LY3372689: Eli Lilly & Co.

LY3372689 is an orally active O-GlcNAcase (OGA) enzyme inhibitor. O-GlcNAcylation, i.e., addition of N-acetylglucosamine to serine and threonine residues, is a post-translational modification that regulates the function of many proteins. In particular, N-GlcNAcylation of tau reduces its propensity to form toxic aggregates. OGA catalyzes removal of O-GlcNAc. OGA inhibitors promote tau glycosylation, prevent aggregation, and appear to stabilize tau in a soluble, nonpathogenic form. LY3372689 can be used for tauopathies research, including Alzheimer’s disease. Currently the drug is in Phase II stage of Clinical trial evaluation for the treatment of Alzheimer’s disease.

 

  • CT1812: Cognition Therapeutics

Cognition Therapeutics isdeveloping CT1812, an oral, brain-penetrant, small molecule therapeutic, which has been shown to protect neurons and synapses by preventing the binding of toxic oligomers. CT1812 acts as a neuroprotective agent both by shielding neurons and synapses from oligomer binding and by preventing oligomers from attaching to synapses in the first place. CT1812 may help mitigate the neurotoxic effects, slowing cognitive decline and progression of Alzheimer’s disease. Currently, the drug is in the Phase II stage of development to treat Alzheimer’s-disease.

 

  • ABBV-916: AbbVie Inc.

ABBV-916 anti-AβpE3 (N-terminal truncated, pyroglutamate-modified at amino acid position 3, amyloid beta) is a monoclonal antibody being investigated for the treatment of Alzheimer’s Disease. The drug candidate is administered through intravenous route as an infusion. Currently, the drug is in the Phase II stage of development to treat Alzheimer’s-disease.

 

  • ALX-001: Allyx Therapeutics, Inc.

ALX-001 (previously BMS-984923) is a silent allosteric modulator of mGluR5, a first-in-class compound that selectively blocks the pathogenic activation of the receptor while preserving the physiological glutamate signaling that is required for normal cognition. ALX-001 has a wide therapeutic window that can saturate receptor binding while avoiding on-target toxicity observed with negative allosteric modulators. Currently, the drug is in the Phase I stage of development to treat Alzheimer’s disease.

 

Learn more about Alzheimer’s Disease Drugs opportunities in our groundbreaking Alzheimer’s Disease research and development projects @ Alzheimer’s Disease Unmet Needs

 

Alzheimer’s Disease Companies

AriBio Co., Ltd., Eli Lilly & Co., Cognition Therapeutics, AbbVie Inc., Allyx Therapeutics, Inc., Cassava Sciences, BioVie Inc., Novo Nordisk, Alector Inc., Longeveron Inc., TrueBinding, Inc., VT BIO, Luye Pharma Group Ltd., Lexeo Therapeutics, Merck Sharp & Dohme LLC, Regeneration Biomedical, Alnylam Pharmaceuticals, Sinotau Pharmaceutical Group, Eisai Inc., Shanghai Hengrui Pharmaceutical Co., Ltd and others.

 

Alzheimer’s-disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Oral
  • Intravenous
  • Subcutaneous
  • Parenteral
  • Topical

 

Alzheimer’s Disease Products have been categorized under various Molecule types such as

  • Recombinant fusion proteins
  • Small molecule
  • Monoclonal antibody
  • Peptide
  • Polymer
  • Gene therapy

 

Discover the latest advancements in Alzheimer’s Disease treatment by visiting our website. Stay informed about how we’re transforming the future of neurology @ Alzheimer’s Disease Market Drivers and Barriers, and Future Perspectives

 

Scope of the Alzheimer’s Disease Pipeline Report

  • Coverage- Global
  • Alzheimer’s Disease Companies- AriBio Co., Ltd., Eli Lilly & Co., Cognition Therapeutics, AbbVie Inc., Allyx Therapeutics, Inc., Cassava Sciences, BioVie Inc., Novo Nordisk, Alector Inc., Longeveron Inc., TrueBinding, Inc., VT BIO, Luye Pharma Group Ltd., Lexeo Therapeutics, Merck Sharp & Dohme LLC, Regeneration Biomedical, Alnylam Pharmaceuticals, Sinotau Pharmaceutical Group, Eisai Inc., Shanghai Hengrui Pharmaceutical Co., Ltd and others.
  • Alzheimer’s Disease Therapies- Aricept, INM-176, SAR110894, Donepezil, CPC-201, ENA713, Remternetug, and others.
  • Alzheimer’s Disease Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Alzheimer’s Disease Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

 

For a detailed overview of our latest research findings and future plans, read the full details of Alzheimer’s Disease Pipeline on our website @ Alzheimer’s Disease Emerging Drugs and Companies

 

Table of Content

  1. Introduction
  2. Executive Summary
  3. Alzheimer’s-disease: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Alzheimer’s-disease– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. AR1001: AriBio Co., Ltd.
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. LY3372689: Eli Lilly & Co.
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. ALX-001: Allyx Therapeutics, Inc.
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug name: Company name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Alzheimer’s-disease Key Companies
  21. Alzheimer’s-disease Key Products
  22. Alzheimer’s-disease- Unmet Needs
  23. Alzheimer’s-disease- Market Drivers and Barriers
  24. Alzheimer’s-disease- Future Perspectives and Conclusion
  25. Alzheimer’s-disease Analyst Views
  26. Alzheimer’s-disease Key Companies
  27. Appendix

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/report-store/knee-reconstruction-devices-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Alzheimer’s Disease FDA Approvals, Clinical Trials, Emerging Drugs, Pipeline Insights and Companies | DelveInsight